Literature DB >> 21102567

Anandamide serves two masters in the brain.

Vincenzo Di Marzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21102567     DOI： 10.1038/nn1210-1446

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  15 in total

1.  TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons.

Authors:  Helen E Gibson; Jeffrey G Edwards; Rachel S Page; Matthew J Van Hook; Julie A Kauer
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

2.  Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.

Authors:  L Cristino; L de Petrocellis; G Pryce; D Baker; V Guglielmotti; V Di Marzo
Journal:  Neuroscience       Date:  2006-04-17       Impact factor: 3.590

3.  Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.

Authors:  Mauro Maccarrone; Silvia Rossi; Monica Bari; Valentina De Chiara; Filomena Fezza; Alessandra Musella; Valeria Gasperi; Chiara Prosperetti; Giorgio Bernardi; Alessandro Finazzi-Agrò; Benjamin F Cravatt; Diego Centonze
Journal:  Nat Neurosci       Date:  2008-01-20       Impact factor: 24.884

4.  Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.

Authors:  Vincenzo Micale; Luigia Cristino; Alessandra Tamburella; Stefania Petrosino; Gian Marco Leggio; Filippo Drago; Vincenzo Di Marzo
Journal:  Neuropsychopharmacology       Date:  2008-06-25       Impact factor: 7.853

5.  Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways.

Authors:  Katarzyna Starowicz; Sabatino Maione; Luigia Cristino; Enza Palazzo; Ida Marabese; Francesca Rossi; Vito de Novellis; Vincenzo Di Marzo
Journal:  J Neurosci       Date:  2007-12-12       Impact factor: 6.167

6.  TRPV1 channels control synaptic plasticity in the developing superior colliculus.

Authors:  Sabatino Maione; Luigia Cristino; Anna Lucia Migliozzi; Anne L Georgiou; Katarzyna Starowicz; Thomas E Salt; Vincenzo Di Marzo
Journal:  J Physiol       Date:  2009-04-30       Impact factor: 5.182

7.  Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.

Authors:  Eva de Lago; Rosario de Miguel; Isabel Lastres-Becker; José A Ramos; Javier Fernández-Ruiz
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

Review 8.  TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications.

Authors:  Katarzyna Starowicz; Luigia Cristino; Vincenzo Di Marzo
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human.

Authors:  E Mezey; Z E Tóth; D N Cortright; M K Arzubi; J E Krause; R Elde; A Guo; P M Blumberg; A Szallasi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus.

Authors:  Andrés E Chávez; Chiayu Q Chiu; Pablo E Castillo
Journal:  Nat Neurosci       Date:  2010-11-14       Impact factor: 24.884
View more
  19 in total

1.  Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.

Authors:  Plínio C Casarotto; Ana Luisa B Terzian; Daniele C Aguiar; Hélio Zangrossi; Francisco S Guimarães; Carsten T Wotjak; Fabrício A Moreira
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 2.  Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.

Authors:  John M McPartland; Marnie Duncan; Vincenzo Di Marzo; Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2015-02       Impact factor: 8.739

3.  Paradoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues.

Authors:  Erik B Oleson; Joseph F Cheer
Journal:  Synapse       Date:  2012-07-27       Impact factor: 2.562

Review 4.  Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.

Authors:  Antonio Luchicchi; Marco Pistis
Journal:  Mol Neurobiol       Date:  2012-07-17       Impact factor: 5.590

5.  CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model.

Authors:  Guangchen Ji; Volker Neugebauer
Journal:  Eur J Neurosci       Date:  2014-02       Impact factor: 3.386

6.  Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex.

Authors:  Claire L De-May; Afia B Ali
Journal:  J Neurophysiol       Date:  2012-10-10       Impact factor: 2.714

7.  Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.

Authors:  Torbjörn U C Järbe; Brian J LeMay; V Kiran Vemuri; Subramanian K Vadivel; Alexander Zvonok; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2011-03-03       Impact factor: 4.530

Review 8.  Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Authors:  P Pacher; R Mechoulam
Journal:  Prog Lipid Res       Date:  2011-02-02       Impact factor: 16.195

Review 9.  Why do cannabinoid receptors have more than one endogenous ligand?

Authors:  Vincenzo Di Marzo; Luciano De Petrocellis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

10.  Medial prefrontal cortex Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the expression of contextual fear conditioning in Wistar rats.

Authors:  Ana Luisa B Terzian; Daniel Gustavo dos Reis; Francisco S Guimarães; Fernando M A Corrêa; Leonardo B M Resstel
Journal:  Psychopharmacology (Berl)       Date:  2013-08-07       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.